Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140003/S137

Impella 5.5 with Smart Assist

Abiomed, Inc. · Decision date Apr 7, 2026

FDA DECISIONP140003/S137

What did the FDA decide?

FDA records P140003/S137 as a supplement to PMA P140003, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 7, 2026.

FDA approval order statement

the adoption of an additional sterilization site for the Impella 5.5 with SmartAssist S2 configuration into the site's current routine sterilization process established for other Impella products
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Apr 7, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P140003/S137
Regulatory pathway
PMA supplement
Applicant
Abiomed, Inc.
Product code
OZD
Decision code
OK30
Decision date
Apr 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Temporary non-roller type left heart support blood pump.

Applicant
Abiomed, Inc.
Product code
OZD
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P140003/S128 · Related supplement

    Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5 with SmartAssist, and Impella LD

  2. P140003/S123 · Related supplement

    Impella 5.5 with SmartAssist System; Impella CP with SmartAssist System; Impella 2.5; Impella 5.0; Impella LD;

  3. P140003/S124 · Related supplement

    Impella CP with SmartAssist System

  4. P140003/S126 · Related supplement

    Impella 5.5 with SmartAssist, Impella CP with SmartAssist, Purge Cassette

  5. P140003/S129 · Related supplement

    Impella 2.5; Impella CP; Impella CP with SmartAssist; Impella 5.0; Impella 5.5 with SmartAssist; Impella LD

  6. P140003/S130 · Related supplement

    Impella CP with SmartAssist

  7. P140003/S131 · Related supplement

    Impella 5.5 with SmartAssist

  8. P140003/S136 · Related supplement

    Impella CP with SmartAssist; Impella 5.5 with SmartAssist

  9. P140003/S135 · Related supplement

    Impella 2.5 System; Impella CP System; Impella CP with Smart Assist System; Impella 5.0 System, Impella 5.5 with Smart A

  10. P140003/S137 received

    Application receipt date recorded by FDA.

  11. P140003/S137 · FDA decision

    30-Day Notice

  12. P140003/S138 · Related supplement

    Impella CP with SmartAssist

Timeline entries are records held by MedtechLedger for P140003. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140003

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abiomed, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
22 Cherry Hill Dr., Danvers, MA, 01923

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records